---
reference_id: clinicaltrials:NCT07151508
title: Successful Treatment of Netherton Syndrome With Combination of Secukinumab and Dupilumab.
content_type: summary
---

# Successful Treatment of Netherton Syndrome With Combination of Secukinumab and Dupilumab.

## Content

In this study, we describe our experience with secukinumab (IL-17A inhibitor) and dupilumab (IL-4/IL-13 inhibitor) treatment of a group of pediatric patients with severe Neterton syndrome.